Journal of the Korean Society of Radiology (대한영상의학회지)

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Invasive Pulmonary Aspergillosis in a Immunocompetent Patient after Congenital Heart Disease Surgery: A Case Report

면역저하가 없는 환자에서 선천성 심장수술 후 발생한 폐 아스페르길루스증: 증례 보고

  • So-Hyun Ji (Department of Radiology, Korea Cancer Center Hospital) ;
  • Seung-Jin Yoo (Department of Radiology, Seoul National University Hospital) ;
  • Eun-Ah Park (Department of Radiology, Seoul National University Hospital) ;
  • Seung-Geun Song (Department of Pathology, Seoul National University Hospital)
  • Received : 2020.01.23
  • Accepted : 2020.03.10
  • Published : 2020.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Invasive pulmonary aspergillosis (IPA) has been known to occur in immunocompromised patients, but has been rarely reported in immunocompetent patients. In immunocompetent patients, pulmonary fungal infections are not initially considered. This results in diagnosis and treatment delays, as well as poor prognosis. We report a case and serial CT findings of IPA in an immunocompetent 29-year-old male after congenital heart disease surgery.

침습성 폐 아스페르길루스증은 주로 면역저하 환자에서 발생하는 것으로 알려져 있지만 드물게 면역저하가 없는 환자에서도 발생한다. 면역저하가 없는 환자에서 발병하는 경우, 초기에 진균에 의한 폐 감염을 의심하기가 어렵기 때문에 진단 및 치료가 늦어지고 나쁜 예후를 보일 수 있다. 저자들은 면역저하가 없는 29세 남성 환자에서 선천성 심장질환 수술 후 발생한 침습성 폐 아스페르길루스증의 사례가 있어 시간 경과에 따른 CT 소견과 함께 보고하고자 한다.

Keywords

References

  1. Cheon JE, Im JG, Goo JM, Kim HD, Han MC. CT findings of pulmonary aspergillosis. J Korean Radiol Soc 1995;33:903-909  https://doi.org/10.3348/jkrs.1995.33.6.903
  2. Kim SH, Moon SM, Han SH, Chung JW, Moon SY, Lee MS, et al. Epidemiology and clinical outcomes of invasive pulmonary aspergillosis: a nationwide multicenter study in Korea. Infect Chemother 2012;44:282-288  https://doi.org/10.3947/ic.2012.44.4.282
  3. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 2019 [In press] doi: https://doi.org/10.1093/cid/ciz1008 
  4. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008;47:1176-1184  https://doi.org/10.1086/592255
  5. Stevens DA, Melikian GL. Aspergillosis in the 'nonimmunocompromised' host. Immunol Invest 2011;40:751-766  https://doi.org/10.3109/08820139.2011.614307
  6. Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006;12:1060-1076  https://doi.org/10.1111/j.1469-0691.2006.01512.x
  7. Franquet T, Muller NL, Gimenez A, Guembe P, De La Torre J, Bague S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001;21:825-837  https://doi.org/10.1148/radiographics.21.4.g01jl03825
  8. Park SY, Lim C, Lee SO, Choi SH, Kim YS, Woo JH, et al. Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Infect 2011;63:447-456  https://doi.org/10.1016/j.jinf.2011.08.007
  9. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;63:e1-e60  https://doi.org/10.1093/cid/ciw326